Health

Results: 8737-8748 of 9412

Implantica takes a big step forward at its 2nd Annual RefluxStop™ Users Meeting

BerGenBio Reports Third Quarter 2023 Financial Results

Dexcom Warriors from top left to right: Bambi B., Enrrique A., Nenad Š., Qiana D. & Lily D., Nick J. Dexcom Warriors from bottom left to right: Natalie B., Victor G., Patti L., Hayley B., Steven C. (Photo: Business Wire)

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day

HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO

More than two in three people with diabetes already have complications at diagnosis, International Diabetes Federation study finds

MULTI-MILLION POUND BOOST FOR RESEARCH PROJECTS AIMED AT DEVELOPING NEW TESTS, TREATMENTS AND DEVICES FOR NEURODEGENERATIVE DISEASES

PR Newswire associated0

Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam®

PR Newswire associated0

American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI

PR Newswire associated0

Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety

PR Newswire associated0

LIFE FITNESS ANNOUNCES SYMBIO, A FIRST-OF-ITS-KIND PREMIUM CARDIO LINE, REIMAGINING THE FITNESS EXPERIENCE

Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral Treatment, at doses used for Treatment-Resistant Depression

PR Newswire associated0

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)